Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A.

Clinical trials in rheumatoid arthritis: methodological suggestions for assessing radiographs arising from the GRISAR Study. Gruppo Reumatologi Italiani Studio Artrite Reumatoide. Ann Rheum Dis (1997) 1.10

ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial. Arthritis Res Ther (2014) 0.82

Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension. Ann Rheum Dis (2002) 0.82

An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis. Rheumatol Int (2003) 0.80

Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A or methotrexate: comment on the article by Pasero et al. Arthritis Rheum (1997) 0.75

Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med (1981) 7.53

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.83

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J Natl Cancer Inst (1999) 4.04

Optical gain in silicon nanocrystals. Nature (2000) 3.77

Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol (1994) 3.48

Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst (1990) 3.02

Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. Eur J Cancer (1990) 3.01

Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol (2001) 2.89

Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst (1995) 2.52

Bone mineral density in patients with psoriatic arthritis. J Rheumatol (2001) 2.45

The adolescent growth spurt of boys and girls of the Harpenden growth study. Ann Hum Biol (1976) 2.19

Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer. Ann Oncol (2006) 2.10

Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci (1986) 2.07

Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 2.07

Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. Eur J Cancer Clin Oncol (1986) 2.05

Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg (1999) 2.00

Confidence interval estimation for DNA and mRNA concentration by real-time PCR: A new environment for an old theorem. Int J Biol Markers (2004) 1.90

Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years. J Rheumatol (2000) 1.88

Endothelial progenitors in pulmonary hypertension: new pathophysiology and therapeutic implications. Eur Respir J (2010) 1.83

Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Rheumatology (Oxford) (2006) 1.74

The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer (1999) 1.73

Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancer. Eur J Cancer (1998) 1.68

Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy. Cancer J Sci Am (2006) 1.54

Colour Doppler ultrasonography evaluation of vascularization in the wrist and finger joints in rheumatoid arthritis patients and healthy subjects. Eur J Radiol (2010) 1.53

Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis. Br J Rheumatol (1993) 1.52

Skeletal benign bone-forming lesions. Eur J Radiol (1998) 1.48

Interferon adjuvant to radical nephrectomy in Robson stages II and III renal cell carcinoma: a multicentric randomized study. J Clin Oncol (2001) 1.47

A comparative study of tenidap, a cytokine-modulating anti-rheumatic drug, and diclofenac in rheumatoid arthritis: a 24-week analysis of a 1-year clinical trial. Br J Rheumatol (1995) 1.43

Radiographic changes in the feet of patients with early rheumatoid arthritis. GRISAR (Gruppo Reumatologi Italiani Studio Artrite Reumatoide) J Rheumatol (1997) 1.43

Psoriatic arthritis in psoriatic patients. Br J Rheumatol (1984) 1.40

Analysis of disability in knee osteoarthritis. Relationship with age and psychological variables but not with radiographic score. J Rheumatol (1991) 1.40

Quality control for biomarker determination in oncology: the experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT). Int J Biol Markers (2002) 1.40

Changes in regional cerebral blood flow after a cold hand test in systemic lupus erythematosus patients with Raynaud's syndrome. Lancet (2000) 1.39

Effects of exercise on natriuretic peptides and cardiac function in man. Int J Cardiol (1998) 1.39

Malignant lymphoma presenting as Tietze's syndrome. Arthritis Rheum (2002) 1.39

Levels of serum immunoglobulins in patients with rheumatoid arthritis. Ann Rheum Dis (1967) 1.38

Low incidence of proteinuria in RA after gold thiosulfate treatment. J Rheumatol (1990) 1.38

The classification of psoriatic arthritis: what will happen in the future? J Am Acad Dermatol (1997) 1.38

Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review. Rheumatology (Oxford) (2002) 1.37

Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group. Ann Surg (1997) 1.32

In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease. Autoimmunity (2006) 1.27

Feed forward neural networks for the analysis of censored survival data: a partial logistic regression approach. Stat Med (1998) 1.24

Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. J Invest Dermatol (1999) 1.22

HDL-cholesterol and breast cancer: a joint study in northern Italy and southern France. Int J Epidemiol (1993) 1.22

Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol (1988) 1.21

Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed. Ann Rheum Dis (2005) 1.20

Progression of erosion and joint space narrowing scores in rheumatoid arthritis assessed by nonlinear models. J Rheumatol (1994) 1.18

Toxicity due to remission inducing drugs in rheumatoid arthritis. Association with HLA-B35 and Cw4 antigens. J Rheumatol (1986) 1.17

Multicentric reticulohistiocytosis: a rare cause of erosive arthropathy of the distal interphalangeal finger joints. Ann Rheum Dis (2002) 1.15

Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables. J Clin Oncol (2001) 1.15

Prognostic role of serum CA15.3 in 362 node-negative breast cancers. An old player for a new game. Eur J Cancer (2002) 1.12

Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation (1992) 1.11

Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group. J Clin Endocrinol Metab (1998) 1.11

Chronic ochronotic arthritis: clinical, arthroscopic, and pathologic findings. J Rheumatol (2000) 1.11

Giant histiocytes after cyclophosphamide. Experientia (1970) 1.11

New method for expressing survival in cancer. Relation between survival times and patients' age at diagnosis must be taken into account. BMJ (1997) 1.11

Clinical trials in rheumatoid arthritis: methodological suggestions for assessing radiographs arising from the GRISAR Study. Gruppo Reumatologi Italiani Studio Artrite Reumatoide. Ann Rheum Dis (1997) 1.10

[Thrombocytosis in progressive generalized sclerosis (scleroderma) and in other rheumatic diseases]. Z Rheumatol (1978) 1.07

Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood (1995) 1.07

Structural and optical properties of silicon nanocrystals grown by plasma-enhanced chemical vapor deposition. J Nanosci Nanotechnol (2001) 1.06

CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach. CNS Drugs (2001) 1.05

Prevalence of psoriatic arthritis in Italian psoriatic patients. J Rheumatol (1995) 1.05

In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology (Oxford) (2006) 1.05

Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery. Br J Surg (1999) 1.04

Is onset type evaluated during the first 3 months of disease satisfactory for defining the sub-groups of juvenile chronic arthritis? A EULAR Cooperative Study (1983-1986). Clin Exp Rheumatol (1990) 1.04

Psoriasis and psoriatic arthritis. Dermatological and rheumatological co-operative clinical report. Acta Derm Venereol Suppl (Stockh) (1989) 1.03

Peripheral neuropathy in essential mixed cryoglobulinaemia. J Neurol Neurosurg Psychiatry (1992) 1.03

Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE. Clin Exp Rheumatol (1998) 1.03

The arthritis of coeliac disease: prevalence and pattern in 200 adult patients. Br J Rheumatol (1996) 1.02

Simvastatin reduces MMP-3 level in interleukin 1beta stimulated human chondrocyte culture. Ann Rheum Dis (2004) 1.02

HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens (2008) 1.01

Controlled multicenter trial of tiopronin and d-penicillamine for rheumatoid arthritis. Arthritis Rheum (1982) 1.00

A microcomputer program for probit analysis of interleukin-2 (IL-2) titration data. J Immunol Methods (1986) 1.00

Combination treatment with etanercept and an intensive spa rehabilitation program in active ankylosing spondylitis. Int J Immunopathol Pharmacol (2010) 0.99

The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. Ann Rheum Dis (2008) 0.99

Safety of the synthetic retinoid fenretinide: long-term results from a controlled clinical trial for the prevention of contralateral breast cancer. J Clin Oncol (2001) 0.99

Confidence interval for DNA/mRNA concentration by real-time PCR. Int J Biol Markers (2007) 0.99

Clonal expansions of V delta 1+ and V delta 2+ cells increase with age and limit the repertoire of human gamma delta T cells. Eur J Immunol (1994) 0.99

The cervical spine in patients with psoriatic arthritis: a clinical, radiological and immunogenetic study. Ann Rheum Dis (1992) 0.99

Sonographic study of calcaneal entheses in erosive osteoarthritis, nodal osteoarthritis, rheumatoid arthritis and psoriatic arthritis. Scand J Rheumatol (2003) 0.98

Electrophysiologic evaluation of local steroid injection in carpal tunnel syndrome. Arch Phys Med Rehabil (1991) 0.98

Quantum confinement and electroluminescence in ultrathin silicon nanowires fabricated by a maskless etching technique. Nanotechnology (2012) 0.98

Thyroid function in systemic sclerosis. J Endocrinol Invest (1992) 0.98

Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev (2005) 0.97

Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome. Arthritis Rheum (1997) 0.97

Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol (1994) 0.97

Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol (1988) 0.97

Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res (1998) 0.96

Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96

Role of infectious agents in systemic rheumatic diseases. Clin Exp Rheumatol (2008) 0.96

Septic sacroiliitis: an uncommon septic arthritis. Clin Exp Rheumatol (2010) 0.96

Is steroid receptor profile in contralateral breast cancer a marker of independence of the corresponding primary tumour? Eur J Cancer (1998) 0.95

Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders. Autoimmun Rev (2003) 0.95

Early breast cancer: evaluation of the prognostic role of the site of the primary tumor. J Clin Oncol (1998) 0.95

The fit of Gompertz and Logistic curves to longitudinal data during adolescence on height, sitting height and biacromial diameter in boys and girls of the Harpenden Growth Study. Hum Biol (1972) 0.95

Long-term tolerability of fenretinide (4-HPR) in breast cancer patients. Eur J Cancer (1991) 0.95

Extracorporeal shock wave therapy for chronic calcific tendinitis of the shoulder: single blind study. Ann Rheum Dis (2003) 0.95

Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes. J Rheumatol (1999) 0.95